Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CK-107 ex vivo diaphragm fiber study in COPD
NL-OMON40872Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of reldesemtiv in chronic obstructive pulmonary disease (COPD) (2 cohorts), sponsored by Amsterdam University Medical Center. Primary endpoint: Contractile force of single diaphragm muscle fibers. Started Jan 2015; status: active, not recruiting.
02
Drugs
reldesemtiv
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NL-OMON40872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40872.